Delivery Order SPE2DB20D1047-SPE2DB25FF76Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract has a ceiling value of $39,029.03 and an ultimate completion date of September 26, 2025. The contract represents a direct delivery order with no set-aside designation, issued to the prime contractor's corporate office located in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in units of 30 count. This contract, valued at $36,305.86, is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025. The award was made through open competition with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral...
- The Defense Logistics Agency awarded a $10,678.35 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The order is scheduled for ultimate completion on September 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is...
- The Defense Logistics Agency awarded a $19,989.93 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-unit packages). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $5,907.98 and an ultimate completion date of July 22, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $44,569.10 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed price contract. This non-competitive delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units, with a ceiling value of $13,405.77. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an...
- The Defense Logistics Agency awarded a delivery order valued at $8,740.92 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $45,195.34 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $39,414.39 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF76ZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $26,682.54 and an ultimate completion date of August 11, 2025. The contract was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's role in supporting military healthcare pharmaceutical needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive awards across multiple therapeutic domains, serving defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.7k | 8/8/25 |